InfuSystem (NYSE:INFU) Upgraded by Sidoti to "Strong-Buy" Rating

Sidoti upgraded shares of InfuSystem (NYSE:INFU - Free Report) to a strong-buy rating in a research report report published on Tuesday morning,Zacks.com reports.

Separately, StockNews.com raised InfuSystem from a "buy" rating to a "strong-buy" rating in a report on Friday, March 14th.

InfuSystem Stock Performance

Shares of INFU stock traded up $0.24 during trading on Tuesday, reaching $6.07. 117,595 shares of the company's stock traded hands, compared to its average volume of 75,336. The firm's 50-day moving average is $7.39 and its 200 day moving average is $7.54. The company has a market capitalization of $127.52 million, a P/E ratio of 101.18 and a beta of 1.75. InfuSystem has a 1 year low of $5.29 and a 1 year high of $9.97. The company has a current ratio of 1.98, a quick ratio of 1.59 and a debt-to-equity ratio of 0.50.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the company. GSA Capital Partners LLP raised its position in shares of InfuSystem by 23.9% in the third quarter. GSA Capital Partners LLP now owns 65,680 shares of the company's stock worth $440,000 after buying an additional 12,657 shares in the last quarter. Oppenheimer Asset Management Inc. increased its stake in InfuSystem by 28.0% in the 3rd quarter. Oppenheimer Asset Management Inc. now owns 33,337 shares of the company's stock worth $223,000 after acquiring an additional 7,295 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. purchased a new stake in shares of InfuSystem in the 3rd quarter valued at about $87,000. BNP Paribas Financial Markets boosted its position in shares of InfuSystem by 66.4% during the 3rd quarter. BNP Paribas Financial Markets now owns 4,076 shares of the company's stock valued at $27,000 after acquiring an additional 1,626 shares during the last quarter. Finally, State Street Corp grew its holdings in shares of InfuSystem by 1.1% during the third quarter. State Street Corp now owns 267,012 shares of the company's stock worth $1,789,000 after purchasing an additional 3,019 shares in the last quarter. 71.13% of the stock is owned by institutional investors.

Remove Ads

InfuSystem Company Profile

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.